Intravenous immunoglobulin prophylaxis in neonates on artificial ventilation

South African Medical Journal

Volumn 86, Issue 5, 1996, Pages 542-545

  Adhikari, M ^a   Wesley, A G ^a   Fourie, P B ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ANTIBIOTIC THERAPY; ARTICLE; ASSISTED VENTILATION; BACTERIUM CULTURE; BLOOD CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENDOTRACHEAL TUBE; ENTEROBACTER; ESCHERICHIA COLI; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOTHERAPY; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; KLEBSIELLA; LEUKOCYTE COUNT; LUNG DYSPLASIA; NEWBORN; PROPHYLAXIS; PSEUDOMONAS; SEPSIS; STAPHYLOCOCCUS;

BACTERIAL INFECTIONS; CROSS INFECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; MALE; PLACEBOS; RESPIRATION, ARTIFICIAL;

EID: 0029892727     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Chirico G, Rondini G, Diebani A, Chiara A, Massa M, Ugazio AG. Intravenous gammaglobulin therapy for prophylaxis of infection in high risk neonates. J Pediatr 1987; 110: 437-442.
2. Noya FJD, Baker CJ. Intravenously administered immune globulin for premature infants: A time to wait (Editorial). J Pediatr 1989; 115: 969-971.
3. Gonzalez LA, Hill HR. The current status of intravenous gammaglobulin use in neonates. Pediatr Infect Dis J 1989; 8: 315-322.
4. Bancalari E, Gerhardt T. Bronchopulmonary dysplasia. Pediatr Clin North Am 1986; 33: 1-22.
5. Vain NE, Mazlumian JR, Swarner W, Cha CC. Role of exchange transfusion in the treatment of severe septicaemia. Pediatrics 1980; 66: 693-697.
6. Cairo MS, Rucker R, Bennett GA, Hicks D, Worcester C, Amlie R. Improved survival of newborns receiving leucocyte transfusions for sepsis. Pediatrics 1984; 74: 887-892.
7. Adhikari M, Coovadia HM, Gaffin SL, et al. Septicemic low birth weight neonates treated with human antibodies to endotoxin. Arch Dis Child 1985; 60: 382-384.
8. Stiehm ER. Role of immunoglobulin therapy in neonatal infections: Where we stand today. Rev Infect Dis 1990; 12: 439-442.
9. Haque KN, Zaidi MH, Haque SK, et al. Intravenous immunoglobulin for the prevention of sepsis in preterm and low birth weight infants. Pediatr Infect Dis J 1986; 5: 622-625.
10. Bussel JB. Intravenous gammaglobulin in the prophylaxis of late sepsis in very-low-weight infants: Preliminary results of a randomized, double-blind, placebo-controlled trial. Rev Infect Dis 1990; 12: 457-461.
11. Clapp DW, Kliegman RM, Baley JE, et al. Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: Report of a pilot study. J Pediatr 1989; 115: 973-978.
12. Baker CJ, Rench MA, Noya FJD, Garcia Prats JA and Neonatal IVIG study group. Role of intravenous immunoglobulin in prevention of late-onset infection in low birth weight neonates. Rev Infect Dis 1990; 12: 5463-5468.
13. Kyllonen KS, Clapp DW, Kliegman RM, et al. Clinical and laboratory observations. Dosage of intravenously administered immunoglobulin and dosing interval required to maintain target levels of immuno-globulin G in low birth weight infants. J Pediatr 1989; 115: 1013-1016.
14. Esser M, Pieper C, Thom CJ, et al. The effect of single high dose intravenous immunoglobulin in the infection related morbidity and mortality in selected pre-term neonates. Paper presented at the Joint Biennial Congress of the South African Paediatric Association, Wilderness, Cape, 26-30 August 1990.
15. Givner LB. Human immunoglobulins for intravenous use: Comparison of available preparations for Group B streptococcal antibody levels, opsonic activity and efficacy in animal models. Pediatrics 1990; 86: 955-962.
16. Weisman LE, Lorenzetti PM. High intravenous doses of human immune globulin suppress neonatal group B streptococcal immunity in rats. J Pediatr 1989; 115: 445-450.
17. Baker CJ, Kasper DL. Group B streptococcal vaccines. Rev Infect Dis 1985; 7: 458-467.
18. Raff HV, Devereux D, Shuford W, Abbot-Brown D, Maloney G. Human monoclonal antibody with protective activity for Escherichia coli K, and Neisseria meningitis group B infections. J Infect Dis 1988; 157: 118-125.
19. Raff HV, Siscoe PJ, Wolff EA, Maloney G, Shuford W. Human monoclonal antibodies to group Streptococcus reactivity and in vivo protection against multiple serotypes. J Exp Med 1988; 168: 905-917.